Albertsons Companies, Domino’s Pizza And Other Big Gainers From Thursday
U.S. stocks closed higher on Thursday, with the Dow Jones jumping over 800 points. Here is the list of some big stocks recording gains in the previous session.
Why Laser Photonics Shares Are Trading Higher By Around 44%, Here Are 50 Stocks Moving In Thursday’s Mid-Day Session
Gainers
FedNat Holding Company (NASDAQ: FNHC) shares jumped 89% to $0.4242 after dipping 34% on Wednesday.
Delta Air Lines, Walgreens Boots Alliance And Some Other Big Stocks Moving Higher In Today’s Pre-Market Session
U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session.
Jim Cramer On This Industrial Stock: ‘You Don’t Know What’s In It’
On CNBC’s "Mad Money Lightning Round," Jim Cramer recommended buying Sociedad Quimica y Minera de Chile (NYSE: SQM) as "fertilizer’s in short supply and so is lithium."
Jefferies Maintains Buy on Axsome Therapeutics, Lowers Price Target to $90
Jefferies analyst Chris Howerton maintains Axsome Therapeutics (NASDAQ:AXSM) with a Buy and lowers the price target from $92 to $90.
10 Health Care Stocks Whale Activity In Today’s Session
This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
Important Biotech Catalysts For September 8, 2022 – End Of The Day Summary
The United States Food and Drug Administration (FDA) has approved Revance Therapeutics’ (NASDAQ:RVNC) lead asset DAXXIFY (DaxibotulinumtoxinA-lanm) for…
Mizuho Bolsters Price Target By 55% On This Migraine Stock
Mizuho Securities assumes coverage of Axsome Therapeutics Inc (NASDAQ:AXSM), with a Buy rating and a price target of $76, representing a 25%…
Mizuho Assumes Axsome Therapeutics at Buy, Announces Price Target of $76
Mizuho analyst Graig Suvannavejh assumes Axsome Therapeutics (NASDAQ:AXSM) with a Buy rating and announces Price Target of $76.